Loading clinical trials...
Loading clinical trials...
Successful treatment of hepatitis C has been reported to be associated with 62-84% reduction in all-cause mortality (deaths), 68-79% reduction in risk of HCC and 90% reduction in risk of liver transpl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
NCT06953479 · HEPATITIS C (HCV), Incarceration, and more
NCT04162938 · Hepatitis C
NCT03135886 · HIV/AIDS, Hepatitis C, and more
NCT05968573 · Human Immunodeficiency Virus (HIV), Hepatitis C (HCV)
NCT07024628 · Heathly Subjects, Primary Health Care, and more
Post Graduate Institute of Medical Education and Research
Chandigarh
Postgraduate Institute of Medical Education and Research
Chandigarh
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions